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Osteoarthritis is a degenerative joint disease and a world-wide healthcare burden. Characterized by
cartilage degradation, subchondral bone thickening and osteophyte formation, osteoarthritis inﬂicts
much pain and suffering, for which there are currently no disease-modifying treatments available. Mouse
models of osteoarthritis are proving critical in advancing our understanding of the underpinning mo-
lecular mechanisms. The STR/ort mouse is a well-recognized model which develops a natural form of
osteoarthritis very similar to the human disease. In this Review we discuss the use of the STR/ort mouse
in understanding this multifactorial disease with an emphasis on recent advances in its genetics and its
bone, endochondral and immune phenotypes.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Introduction
Animal models are a vital tool for the study of osteoarthritis
(OA). In particular they provide scope to examine the early
aetiological processes where equivalent human samples are
difﬁcult to obtain, and they remain necessary in developing and
testing new treatments1. Animal OA models consist broadly of
those requiring invasive manipulation, such as surgical joint
destabilization by ligament transection or meniscectomy, those
destabilizing the joint without surgical manipulation such as
collagenase-induced instability, those exploiting non-surgical
application of mechanical trauma, or those in which OA de-
velops naturally2e4. Surgical models are representative chieﬂy of
trauma-induced secondary human OA, whilst natural models
offer an opportunity to investigate OA without known aetiology,
akin to primary OA5. All of these OA models principally use the
mouse; well-used mainly due to the ease with which its genome
can be manipulated and because of its robust breeding capacities,
easy husbandry and price of upkeep. In addition, its relatively
short life-span allows for the examination of OA progression, from.A. Staines, School of Applied
us, Edinburgh EH11 4BN, UK.
uk (K.A. Staines), b.poulet@
.N. Wentworth), apitsillides@
r Ltd on behalf of Osteoarthritis Reinitiation to late degenerative stages, to be undertaken in a
compressed timescale.
Numerous mouse strains develop OA with advancing age, of-
fering proof that genetic predisposition or susceptibility is an
important factor. They, nonetheless, develop OA with differing in-
cidences6; high incidence and severity was identiﬁed in the STR/1N
mouse, fromwhich the inbred STR/ort strain is directly derived. The
STR/ort mouse is a well-recognized model of spontaneous OA and,
to date, has featured in over 80 studies. STR/ort mice develop OA
spontaneously early in life and show many human OA character-
istics, including proteoglycan (PG) loss, articular cartilage (AC)
ﬁbrillation, active extracellular matrix (ECM) degradation, osteo-
phyte formation and subchondral sclerosis. Herein, we will revisit
(see Watanbe et al., 2011 and Mason et al., 20017,8) past and new
data from STR/ort mice with view to revealing how they inform our
understanding of early aetiology, pathophysiology and potential
treatment of OA.Origins of the STR/ort mouse
The STR/1N strain was ﬁrst isolated by Strong (1951) during an
extensive selective-breeding programme designed to identify traits
for resistance to tumour induction at the site of injected carcino-
gens9. Tandem crosses between CBA, N, J and K strains generated a
new NH strain that was treated for multiple generations with the
carcinogen, 20-methylcolanthrene creating the NHO strain. Furthersearch Society International. This is an open access article under the CC BY license
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with a piebald mutation and serendipitous generation of the STR/
1N strain7, which exhibited obesity and spontaneous OA at a young
age10. After some breeding without brother-sister pairing and
arrival at the Institute of Orthopaedics, Stanmore (UK), the strain
was renamed STR/ort, as it is now commonly known. The CBA
mouse is the only remaining parental strain available today and it's
lack of overt OA makes it effective as a control11.
STR/ort mouse OA phenotype
STR/ort OA susceptibility genetics are uncertain and their
phenotype is better characterised. STR/ort mice develop OA in knee,
ankle, elbow and temporomandibular joints12e15. The ﬁrst studies
by Walton described a greater incidence of OA knee pathology in
male than in female STR/ort mice; a sexual dimorphism in this
model which is the opposite to that in the human disease16,17. In
male mice, Walton reported steadily increasing OA incidence and
severity from 18 weeks of age. We have shown, by toluidine blue
staining followed by the internationally-recognized OARSI grading
system18, that the OA in the STR/ort mouse invariably predominates
on the medial tibial plateau at the cruciate ligament insertion, is
followed by AC clefting/ﬁbrillation extending centrally and then
later to medial femoral condyles and is accompanied by osteophyte
development and by subchondral bone sclerosis which, with
extensive AC loss across both condyles, later becomes exposed.
Chondrogenesis and ossiﬁcation in collateral/cruciate ligaments,
and meniscal hyperplasia, ossiﬁcation and eburnation is seen in
severely affected joints. This is consistent with greater chondrocyte
proliferation, synovium hyperplasia and cluster formation in
menisci of STR/1N mice19 described as tentative evidence for
reparative processes. It fails to match, however, with prominent
synovial inﬂammatory inﬁltrates seen in STR/ort mice by some. Our
recent work examining whether gait changes are a meaningful
measure of STR/ort OA severity showed that age-related modiﬁ-
cations in paw area precede OA onset and may therefore be useful
for longitudinal monitoring of OA development in these mice20.
Only a few studies have explored OA-associated pain in this
model. Increased basal and evoked prostaglandin E2 release has
been observed in knee preparations from 18-week-old STR/1N
mice, which may enhance nociceptor sensitivity and chronic OA
pain21. However, we have found that male STR/ort mice do not
exhibit any pain-associated behaviours with OA development, even
when treated with the opioid antagonist naloxone20. They did
however exhibit normal pain behaviours in response to complete
Freund's adjuvant-induced arthritis, suggestive that these mice are
not inherently insensitive to joint pain20. Despite this, the precise
nature of OA pain in STR/ort mice is unresolved.
Mechanical aetiology of OA in the STR/ort mouse
Several lines of evidence suggest that OA development in STR/
ort mice involves a mechanical contribution. Indeed, Walton (1977)
showed a close relationship between AC lesions and medial patella
dislocation, medial collateral ligament calciﬁcation/ossiﬁcation and
lateral subluxation of the femur16 and that surgical patella ﬁxation
decreased OA, whereas patella dislocation in CBA mice induced
OA22. Patella dislocation has also been linked to abnormal tibial
internal torsion in STR/ort (STR/OrtCrlj) mice and to advanced age,
leading Naruse et al. (2009) to propose this as the cause of STR/ort
OA23. However, Das-Gupta et al., reported an incidence of patella
dislocation in only 22% of STR/ort mice, reinforcing this with
radiological studies showing not all mice with OA had displaced
patellae, demonstrating that this cannot be a primary event24. We
ﬁnd that patella dislocation correlates with severe OA, but can beabsent even in some STR/ort mice with severe AC degeneration
(unpublished data). Other studies have indicated that this medial
patellar luxation in STR/1N mice is likely due to medial tibia AC
degeneration, pronounced instability and varus knee joint defor-
mity, which contrasts with the valgus characterising knee OA in
C57/Bl6 mice25,26. Mechanical changes induced by patella disloca-
tion could nonetheless be an important contributor and aggravator
of OA development in STR/ort mice.
Development of ankle OA in STR/ort mice has similarly been
linked with calcaneal dislocation, with elevation progressively
more pronounced in ageing mice where it eventually became par-
allel to the distal tibia (unpublished). The cause for this ankle
deformity is unknown, but suggests a possible defect in maintain-
ing joint stability with spontaneous subluxation and later severe
disruption of navicular and tarsal bones in male STR/ort mice15.
Together, these studies suggest a widespread instability phenotype
that disrupts joint mechanics to promote OA. This was however
deemed unlikely by scoring of multiple STR/ort mouse joints which
found that patellar and calcaneal displacements rarely occurred in
the same limb, suggesting they were likely independent events12.
The anterior cruciate ligaments of STR/ort mice also exhibit
lower ultimate strength, increased collagen metabolism andmatrix
metalloproteinase (MMP) activity compared to CBA mice at
20e30 weeks27,28. This suggests that STR/ort mice have inherently
weaker ligaments, which could facilitate patella dislocation and
joint instability. Changes in ligaments and menisci in STR/ort OA
joints, with chondrogenesis and ossiﬁcation, are also seen in sur-
gical OA models, supporting their mechanical aetiology. These
changes would, in turn, modify the mechanical properties of the
ligaments and cause further joint damage.
We have recently explored the importance of mechanical
loading in lesion induction and pathological OA progression in STR/
ort mice using a non-invasive knee joint traumamodel29. We found
that AC in STR/ort mice is relatively resistant to mechanical trau-
maeit can bear greater applied loads without failureewhich is
associated with thicker AC at all ages relative to CBA mice29. These
data suggest that STR/ort mouse OA susceptibility is unlikely due to
enhanced vulnerability of AC to mechanical lesion induction. We
did, however, ﬁnd that repetitive mechanical loading over a two
week-long period promoted progression of spontaneously-
occurring AC lesions in the medial tibia, suggesting that mechani-
cal disturbances may nevertheless accelerate OA progression in
these mice29. This merges well with human studies showing that
mechanical loading of joints is likely a major determinant of both
OA onset and progression and further highlights the attractiveness
of the STR/ort mouse as a model for exploring interplay with me-
chanical factors in OA development.
Genetic studies in the STR/ort mouse
Numerous genetic and microarray analyses have been per-
formed in STR/ort mice. Studies by Jaeger et al. (2008) conﬁrmed
Mendelian OA inheritance and concluded that its polygenicity
means that the allelic subset involved in OA predisposition unlikely
reaches signiﬁcance in any single-Quantitative Trait Loci (QTL)
analysis30. Genotyping of male F2 (STR/ort  C57BL/6) using 96
microsatellite markers and phenotyping by weight, serum COMP
biomarker levels and knee OA revealed three weight-, one serum
COMP- and one OA-associated QTL on chromosome 830. Back-
crossing F1 STR/ort male to C57BL/6N females and linkage by mi-
crosatellite markers, again showed polygenicity with a QTL for OA
instead mapped to a 20 centimorgan region, proximal to chromo-
some 4's centromere (another linked to OA onset in C57BL/6N mice
on chromosome 5 was identiﬁed)31; together these data might
simply support the existence of multiple murine OA loci.
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revealed Wnt-related genes associated with altered chondro-
genesis, including dickkopf 4 (Dkk4), secreted frizzled related protein
1 (Sfrp1) and ﬁbroblast growth factor 1 (Fgfr1), with 23 polymorphic
changes in the Sfrp1 gene identiﬁed in STR/ort in comparison to
C57BL/6 mice32, suggesting that reduced Sfrp1 expression not only
increases Wnt/b-catenin signalling early in life but also renders the
AC prone to premature OA32. This is similar to various genome-
wide expression proﬁling studies in human OA which have also
identiﬁed members of the Wnt/b-catenin signalling pathway as
candidate genes associated with OA.33,34
Our recent studies also support an epigenetic contribution to
STR/ort OA (unpublished). Careful joint OA scoring in individually-
tracked male mice at 26 weeks of age found an important maternal
inﬂuence, with a signiﬁcant correlation between OA severity and
maternal litter parity, and to a lesser extent with maternal age.
Interestingly, no correlations were found with litter size nor with
the time between litters, which suggests an important maternal
inﬂuence during embryo development that underpins OA severity
in STR/ort mice.Articular cartilage phenotype of STR/ort mice
Matrix remodelling
STR/ort mouse AC undergoes structural demise similar to hu-
man OA. Morphologically, STR/ort mouse AC is thicker than in CBA,
and whilst STR/ort chondrocytes express a normal spectrum of PGs
and collagens, there are early changes in AC matrix integrity and
chondrocyte phenotype and function35e37. These include a subtle,
yet progressive decay in PG orientation prior to any decline in
quantity, which was proposed to reﬂect the increased free water-
content characteristic of human OA38. In addition, STR/ort mouse
AC catabolic and anabolic gene expression proﬁles closely resem-
bled those seen in other mouse OA models and in human OA11,
consistent with increased MMP expression and activity37,39,40. The
importance of MMPs in AC degradation in STR/ort mice has been
tested by administration of Ro 32-3555, an orally active collagenase
selective inhibitor which protected against OA development
(Table I)41. In addition, intra-articular injections of CRB0017 (anti-
ADAMTS5 antibody) dose-dependently slowed OA progression in
STR/ort mice ageing from 5 to 8 months (Table I)42. The likelihood
that the STR/ort mouse model will help identify new preventative,
protective and curative avenues targeting AC in OA joints is
therefore well supported.
Subtle changes in STR/ort AC matrix composition, and in
glycosaminoglycan PG content in particular, is observed in STR/ort
male mice in comparison to age-matched CBA mice36,43. Indeed,
chondroitin sulphate content, predominantly C6S, is elevated in
STR/ort mice at 8e19 weeks (before OA onset), decreases at
24e26 weeks of age, before increasing again thereafter (after OA
onset)36. These changes in AC composition may therefore impact
AC function prior to OA onset and this highlights potential targets
for therapeutic intervention.Table I
A summary table of some therapeutics tested in the STR/ort mouse model and their out
Agent Action Outcome
Naloxone Opiod antagonist No signs of p
Ro 32-3555 Collagenase inhibitor Reduction in
against AC de
CRB0017 Anti-ADAMTS5 antibody Dose-depend
Vitamins E, C, A, B6, B2, and selenium Dietary supplementation Lower OA incChondrocyte phenotype
Alternative approaches to redress the lack of therapeutics in OA
are also now emerging. Evidence suggests that the normally ‘stable’
AC chondrocyte adopts a more ‘transient’ phenotype similar to
growth plate chondrocytes in OA35,44e46. This phenotype switching
also occurs in STR/ort mice with the hypertophic marker Col10a1
mRNA signiﬁcantly increasing in STR/ort AC compared to non-OA
AC11,35,47. Consistent with this, Col10a1 immunolabelling has been
observed throughout AC of STR/ort mice before histological OA is
detected35.
TUNEL-positive chondrocytes are observed around OA lesions in
STR/ort AC, indicating apoptosis and chondrocyte transiency,
correlating with OA progression48. The lack of any changes in the
ratio of Bax:Bcl-2 in STR/ort AC48 indicates that this apoptosis is
perhaps attributable instead to increased chondrocyte adenosine
production49. Aberrant control of upstream regulators of apoptosis
have also been found in STR/ort mouse AC; including prohibitin-1, a
proteinwhich restricts generation of reactive oxygen species (ROS),
mitochondrial disorganization, abnormal cristae morphology and
increased sensitivity towards stimuli-elicited apoptosis50. In both
STR/ort, and human AC, accumulation of prohibitin-1 along with
Pitx1 repression was detected in OA chondrocyte nuclei, consistent
with elevated apoptosis.
It appears that STR/ort mouse AC chondrocytes also have an
altered metabolic phenotype, with those in OAeprone regions
having low lactate and succinate dehydrogenase activities prior to
OA onset51,52. This aberrant metabolic phenotype is also evident in
lower glucose 6-phosphate dehydrogenase activity and different
monoamine oxidase localisation speciﬁcally in AC regions where
OA develops53e55; the latter exhibiting potential for therapeutic
targeting in STR/ort mice.Cell signalling pathways
Discovery of the molecular determinants of OA in STR/ort mice
will undoubtedly shed light upon OA aetiopathogenesis in other
species and as such, have been well investigated. Our transcrip-
tional proﬁling of STR/ort AC at various ages revealed differential
regulation of many signalling pathways11, including an underex-
plored pathway relating to genes normally associated with the
contractile machinery of muscle cells; expression of this gene
subset is high in both young STR/ort and CBA mice, but remains
high in OA STR/ort when a signiﬁcant decrease is seen in healthy
CBA aged samples11.
Major pathways such as those provoked by the transforming
growth factor (TGF) b superfamily have already been investigated.
Expression of TGF-b1 was indeed elevated during OA development
in STR/ort compared to age-matched CBA mice56. Further, AC
chondrocyte TGF-b3 and SMAD-2P protein expression decreased in
STR/ort mice with advancing OA severity, except in areas of
osteophyte formation where elevated levels persisted57; blocking
studies suggest that TGF-b3 is involved in early and bone
morphogenetic proteins (BMPs) in late osteophytogenesis57,58.comes
Ref.
ain-associated behaviours 20
joint space narrowing, osteophyte formation and protection
gradation and subchondral bone sclerosis
41
ently slowed OA progression in STR/ort mice ageing from 5 to 8 months 42
idence 65
K.A. Staines et al. / Osteoarthritis and Cartilage 25 (2017) 802e808 805Effective regulation of the Wnt pathway is proving critical in OA
joint pathology59 and levels of sFRP1, the Wnt inhibitor, are
reduced in AC chondrocytes of young STR/ort mice32. We have re-
ported a role for another Wnt inhibitor, sclerostin. This shows
marked enrichment at the osteochondral interface in the relatively
unaffected lateral tibia but its expression was severely disrupted in
medial tibial regions showing AC loss and subchondral bone
thickening35. Similar differential expression patterns of matrix
extracellular phosphoglycoprotein (MEPE), an inhibitor of cartilage
matrix mineralisation60 and downstream sclerostin target61, were
also observed in STR/ort mice, implicating a novel mechanism by
which sclerostin, and hence Wnt signalling functions in OA35,59.
Hypoxia inducible factor 1 (HIF-1a) also plays a major role in joint
homeostasis and its inhibition rapidly provokes OA development in
Balb/C mice. Intriguingly, HIF-1a stabilisation failed to prevent OA
in STR/ort mice62 which further supports use of STR/ort mice in
discerningwhether identical pathological pathways are common to
all forms of OA.
Oxidative stress
Oxidative stress has been shown to contribute to OA progres-
sion. In STR/ort mice, oxidative stress (malondialdehyde) and the
collagen type II degradation (CTX-II) biomarker levels are both
higher than in CBAmice prior to OA onset, suggesting that oxidative
stress is linked to AC type II collagen degradation63. Even before OA
onset, young STR/ort mice show decreased levels of extracellular
superoxide dismutase, the major scavenger of extracellular ROS in
AC, and elevated nitrotyrosine formation at all ages, suggesting that
inadequate control of ROS plays a pathophysiological role in OA64.
This role is supported by markedly lower OA incidence in STR/1N
mice following dietary supplementation (Table I)65. More recently,
apurinic/apyrimidinic endonuclease 2 (Apex 2) was also claimed to
play a critical role in DNA repair caused by oxidative damage in STR/
ort (STR/OrtCrlj) joints66.
Bone phenotype of the STR/ort mouse
Subchondral bone thickening (sclerosis) in OA joints, although
often considered secondary, is nonetheless one of the earliest
detectable changes and we have observed sclerosis in STR/ort
joints with OA onset and development35. This agrees with
decreased osteoclastogenesis (85Sr incorporation), increased
bone apposition that is spatially associated with AC lesions in
early STR/ort mouse OA (polychrome sequential bone labelling)
and with early MRI in STR/ort mice where changes in patellar
tendon and local sclerosis were identiﬁed67,68. They are also
consistent with a recent comprehensive multimodal micro-
computed tomography study which determined compartment-,
age- and site-speciﬁc changes in subchondral bone in STR/ort
mice evoking temporal changes that lead to an altered architec-
ture contributing to their OA phenotype69.
STR/ort mice also have a generalised high bone mass phenotype
in cortical and trabecular compartments too (vs C57Bl/6), associ-
ated with elevated osteoblast numbers and activity, and impaired
osteoclast function70. Indeed, changes in bone remodelling have
already been implicated in the early stages of STR/ort mouse OA,
where raised urinary CTX-II levels were apparent in an OA sub-
group of STR/ort mice (vs non-OA subgroup71). Consistent with an
inherent bone phenotype, we have recently reported that young (6-
week) STR/ort have increased cortical and trabecular parameters in
comparison to age-matched CBA mice35. Surprisingly, this differ-
ence is noted signiﬁcantly earlier and is more marked in female
STR/ort mice, with an almost complete bone marrow compression
and extramedullary haematopoiesis observed by 9 months70. Thisraises an interesting paradox regarding sexual dimorphism in this
strain, where females showeon one handehigher bone mass and
protection from reproducible AC degeneration and whereeon the
otheremale OA appears not to be inﬂuenced by hormone sta-
tus37,72. It therefore seems unlikely that high bone mass alone is
sufﬁcient to accelerate OA onset. Sexually dimorphic OA develop-
ment might instead be due to architectural bone differences. Thus,
early internal tibial torsion and lower cancellous bone mineral
density evident in males may explain the differential incidence of
OA in this STR/ort strain73.
Clues to these changing osteochondral relationships in STR/ort
micemight be evident in the endochondral ossiﬁcation required for
long bone growth. We recently observed accelerated growth dy-
namics in comparison to CBAmice with STR/ort mice exhibiting (1)
an acceleration in body weight gain and tibia length at sexual
maturity (2) Col10a1 and MMP13 expression widely dispersed into
the growth plate proliferative zone (3) differences in growth plate
maturation zone sizes (4) a dramatic acceleration of growth plate
closure with bone bridge formation particularly clustered to medial
areas where OA later predominates35. Together these studies sug-
gest that STR/ort mice have an inherent endochondral ossiﬁcation
defect that drives their OA pathology. Interestingly, the relationship
between longitudinal long bone growth rates and OA development
in humans is a completely unexplored area. It is intriguing none-
theless that canine hip dysplasia, a hereditary predisposition to
degenerative OA, is more common in certain breeds, in particular
those larger breeds which tend to grow more rapidly74.
STR/ort mouse immune phenotype
Although OA is not primarily a classic inﬂammatory disorder, it
is accepted that cytokines play an important pathogenic role75.
Indeed, Chambers et al. (1997) found elevated IL-1b levels in AC
chondrocytes of STR/ort mice at all ages56. In addition, serum levels
of IL-1b, IL-4, IL-10, interferon g were markedly higher in STR/ort
mice76. Our previous microarray analysis in AC identiﬁed NFkB
signalling as the main pathway modiﬁed in STR/ort mice (vs CBA11)
and immunolabelling for the NFkB subunit p65 conﬁrmed elevated
levels in AC chondrocytes of STR/ort mice from 8 weeks of age11.
The NFkB pathway is a recognised hub for inﬂammatory signalling
which suggests links between chondrocyte cytokine production
and signalling and catabolic changes in OA cartilage in STR/ort
mice.
Together these studies suggest that STR/ort OA has an important
inﬂammatory component and this is further cemented by obser-
vations of spleen and lymph nodes abnormalities16. We more
recently showed thatmale STR/ort mice possess signiﬁcantly bigger
spleens (with greater cellularity), decreased naïve T cell numbers,
but increased activated T and B cell numbers, indicating a height-
ened inﬂammatory status11. This could perhaps be explained by the
high bone mass phenotype of STR/ort mice (described above) and
compression of the bone marrow necessitating extramedullary
hematopoiesis70. Oxidative stress is associated with increased in-
ﬂammatory mediator production and as such, reported increases in
oxidative stress in STR/ort mice (see above) may provide an alter-
native explanation for these raised inﬂammatory markers levels63.
These studies suggest a central function of inﬂammatory pathways
to in STR/ort mouse OA development; they may also reﬂect a
common molecular aetiology linking these OA and immune
phenotypes.
STR/ort mice exhibit increased AC expression of beta-defensins
3 and 4, broad-spectrum antimicrobial components of innate im-
munity. These ﬁndings offer a link between host defence mecha-
nisms and inﬂammation with AC tissue-remodelling processes77.
Moreover, it is recognised that CGRPmay contribute to human joint
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STR/ort mouse synovium via increased CD11c(þ) macrophages,
with high IL-1b in F4/80(þ) and high CGRP, CLR, and RAMP1 in the
F4/80() cell fraction, which can be ameliorated upon macrophage
depletion, suggesting that synovial macrophages and IL-1b pro-
duction may be suitable therapeutic targets for treating OA pain78.
Obesity/metabolic syndrome in the STR/ort mouse
Obesity is now a recognised OA risk factor and it has been re-
ported that the parent STR/1N strain exhibits higher blood
cholesterol and phospholipids compared to DBA/2JN and A/LN
strains10. STR/ort mice have also been described as hypercholes-
terolemic and hyperlipidemic (raised cholesterol, high-density and
low-density lipoprotein, triglyceride and insulin) without different
glucose levels compared to C57Bl6/J and CBA/JN79. Regardless, it
has been suggested that STR/ort mice should not be termed obese
as their weight is signiﬁcantly lower than ob/ob mice80. STR/ort
mice also show low levels of serum adiponectin, a key player in
glucose and lipid metabolism, which resembles human primary
hypertriglyceridemic patients. Despite this, a reduction in body
weight of STR/ort mice, using fenoﬁbrate treatment, did not modify
serum lipid composition nor OA severity81, suggesting that lipid
metabolism anomalies were not the primary cause of spontaneous
OA in STR/ort mice.
More recently, microarrays on STR/ort AC/subchondral bone
described upregulation of 331 genes related to development and
function of connective tissues, and 290 genes downregulated
linked to lipid metabolism, in particular genes that were directly
interacting with peroxisome proliferator-activated receptor (PPAR)
alpha/PPARgamma82. While PPARalpha and PPARgamma mRNA
levels themselves were not signiﬁcantly altered, multiple PPAR
pathway components were, leading the authors to conclude that
decreased PPAR signalling contributes to OA progression in STR/ort
mice by promoting osteoblastogenesis and enhanced bone
formation.
Concluding remarks
The STR/ort mouse is an excellent model of spontaneous oste-
oarthritis with disease pathology starting early in life and showing
many similar characteristics akin to human primary OA. The
phenotype of the STR/ort mouse is well characterised with pa-
thology observed in the knee, elbow, ankle and temporomandib-
ular joints of male mice; this highlights the sexual dimorphism in
this strain, whereby females show higher bonemass and protection
from reproducible AC degeneration. The highly deﬁned and
reproducible disease pathology of the STR/ort mouse has, to date,
offered the unique opportunity to identify the pathological role that
key determinants of the AC and subchondral bone phenotypes play
in spontaneous OA development, highlighting the attractiveness of
this murine model in exploring the aetiopathogenesis of sponta-
neous OA. Whether research in the OA ﬁeld should focus upon pre-
clinical studies or on clinical studies in man is still a matter of
debate, and has been elegantly debated in a recent editorial by
Hunter and Little1. However, with new acceptance that broad
generalisation regarding OA aetiopathogenesis is somewhat dis-
tracting and ﬂawed in our pursuit of a single disease-modifying
treatment, research in the OA ﬁeld will undoubtedly look to utilise
animal models such as the STR/ort mouse to yield greater under-
standing of primary OA. The recent research discussed herein
certainly indicates that a better understanding of the genes, mol-
ecules and processes contributing to STR/ort mouse OA will aide
signiﬁcantly in the identiﬁcation of new preventative, protective
and curative avenues for OA.Author contributions
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